Dr. Nate Permpalung

Dr. Nate Permpalung is an Associate Professor of Medicine and serves as the Director of Mycology Research in the Division of Infectious Diseases and Associate Director for Clinical Trials of Transplant Research Center at Johns Hopkins University School of Medicine. In his capacity as a Transplant Infectious Disease physician at Johns Hopkins Hospital, he provides specialized care to immunocompromised patients, including those who have undergone solid organ transplants and those undergoing cancer treatment. His research focuses are respiratory viral infections, invasive fungal infections, fungal-viral interactions, fungal diagnostics, and human pythiosis. Nationally, Dr. Permpalung has served on the panel for the IDSA Aspergillosis Guidelines development and has held editorial positions as Associate Editor for Medical Mycology and as an Editorial Board Member for the Journal of Heart and Lung Transplantation Open.

Dr. Permpalung is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Pneumocystis Jiroveci Pneumonia, COVID-19, Febrile Neutropenia, and Respiratory Syncytial Virus (RSV) Infection.

Dr. Permpalung is board certified in American Board Of Internal Medicine. He is actively involved in clinical research, co-authoring 80 peer reviewed articles.